In the meantime, if you are taking Ozempic or other similar GLP-1 agonists, its a good idea to keep track of your bowel movements, your farting and other gastrointestinal functions
This was within the range reported by previous real-world studies: 2639% and 1672% of incident users received the 0.5 mg and 1.0 mg formulations, respectively, while 13% to 30% and 6788% of prevalent users received the 0.5 mg and 1.0 mg formulations, respectively [13, 20,21,22]
At the same time, how the active protein, or peptide, in GLP-1 drugs such as oral semaglutide are absorbed through the gut can vary among peoplecausing differences in effectiveness and tolerability, McCoy says
Doctors now need strong clinical reasons to prescribe it off-label